The setback dims the outlook for a medicine Pfizer sees as an important contributor going forward, though some analysts are optimistic about the drug’s chances in another trial.
Pfizer drug acquired in Seagen deal disappoints in lung cancer study
You might be interested in …
Transforming Setbacks into Success: Rice Researchers Pioneer Advanced Wearable Technology
Rice University researchers have developed groundbreaking wearable technology designed to transform setbacks into success. This innovative advancement aims to monitor and enhance physical performance, empowering users to overcome obstacles and achieve their fitness goals.
Thermodynamic studies and optimization of pectinase produced by soil-isolated Aspergillus foetidus and its application in the textile industry
Biotechnology : nature.com subject feeds
Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push
An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.